Search Results 11-20 of 44834 for Two-phase

  1. Phase 2/3 Open-Label Trial Of Sibeprenlimab In The Treatment Of Immunoglobulin A Nephropathy - Mayo Clinic

    This is a phase 2/3 open-label trial to evaluate the long-term safety, tolerability, and efficacy of sibeprenlimab administered subcutaneously (SC) in subjects ...

  2. Phase 2 Study Of Inhaled SNG001 In Mechanically Ventilated Patients With Respiratory Viral Infection - Mayo Clinic

    The goal of this Phase 2 study is to assess about the safety, antiviral biomarker responses and efficacy of SNG001 when given to patients requiring invasive ...

  3. Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients - Mayo Clinic

    The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are ...

  4. A Two-part Phase IIb Trial Of Vigil In Ewing's Sarcoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Randomized, Double Blind, Placebo-controlled Phase 2 Study In Adults With Celiac Disease - Mayo Clinic

    Clinical Trials · Randomized, Double Blind, Placebo-controlled Phase 2 Study In Adults With Celiac Disease · More about research at Mayo Clinic · Mayo Clinic ...

  6. A Phase 1/2 Study Of MRTX0902 In Solid Tumors With Mutations In The KRAS MAPK Pathway - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  7. A Phase 2/3 Study To Investigate The Safety And Efficacy Of Brepocitinib In Adults With Lichen Planopilaris (ALPINE) - Mayo Clinic

    A Phase 2/3 Study To Investigate The Safety And Efficacy Of Brepocitinib In Adults With Lichen Planopilaris (ALPINE) · Overview · Participation eligibility.

  8. Smoking Cessation Trial In Recurrent Acute Pancreatitis And Chronic Pancreatitis - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. Phase 1-2 Study Of Low Dose ASTX727 (ASTX727 LD) In Lower Risk Myelodysplastic Syndromes - Mayo Clinic

    Phase 2, 80 new subjects will be randomized in a 1:1 ratio into 2 doses/schedules. Participation eligibility. Participant eligibility includes age, gender, type ...

  10. A Phase 1-2 Dose-Escalation And Cohort-Expansion Study Of Oral EFT508 In Subjects With Hematological Malignancies - Mayo Clinic

    This clinical trial is a Phase 1-2, open-label, sequential-group, dose-escalation and cohort-expansion study evaluating the safety, pharmacokinetics, ...